Works matching AU Iihara, Hirotoshi
Results: 52
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002).
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1487, doi. 10.7150/jca.91675
- By:
- Publication type:
- Article
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 14, p. 2644, doi. 10.7150/jca.87169
- By:
- Publication type:
- Article
Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 5, p. 676, doi. 10.7150/jca.80517
- By:
- Publication type:
- Article
Association between the Co-administration of Histamine H<sub>2</sub> Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis.
- Published in:
- Journal of Cancer, 2022, v. 13, n. 10, p. 3073, doi. 10.7150/jca.73385
- By:
- Publication type:
- Article
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 10, p. 1202, doi. 10.1111/jdi.14046
- By:
- Publication type:
- Article
MASCC antiemetic consensus recommendations: resource-limited settings.
- Published in:
- Supportive Care in Cancer, 2025, v. 33, n. 3, p. 1, doi. 10.1007/s00520-025-09211-4
- By:
- Publication type:
- Article
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2310894, doi. 10.1001/jamanetworkopen.2023.10894
- By:
- Publication type:
- Article
CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00359-5
- By:
- Publication type:
- Article
Medication reconciliation by pharmacists for pre-admission patients improves patient safety.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00340-2
- By:
- Publication type:
- Article
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00239-w
- By:
- Publication type:
- Article
Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 224, doi. 10.1038/s41416-023-02493-7
- By:
- Publication type:
- Article
Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 2, p. 347, doi. 10.1002/ccr3.2645
- By:
- Publication type:
- Article
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 4, p. N.PAG, doi. 10.3892/mco.2022.2524
- By:
- Publication type:
- Article
Efficacy of cisplatin plus vinorelbine adjuvant chemotherapy with split-dose administration of cisplatin after complete resection of stage II-IIIA non-small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 4, p. N.PAG, doi. 10.3892/mco.2022.2509
- By:
- Publication type:
- Article
Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 6, p. N.PAG, doi. 10.3892/mco.2021.2278
- By:
- Publication type:
- Article
Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10008-2
- By:
- Publication type:
- Article
Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1414037
- By:
- Publication type:
- Article
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 2, p. 409, doi. 10.1007/s10147-015-0908-2
- By:
- Publication type:
- Article
Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy — a retrospective observational study.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40780-021-00210-1
- By:
- Publication type:
- Article
Questionnaire survey to identify meal habits which influence adherence to oral 5‐aminosalicylic acid regimens in patients with ulcerative colitis.
- Published in:
- Journal of Pharmacy Practice & Research, 2021, v. 51, n. 5, p. 374, doi. 10.1002/jppr.1712
- By:
- Publication type:
- Article
Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08136-0
- By:
- Publication type:
- Article
Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08136-0
- By:
- Publication type:
- Article
Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
- Published in:
- Supportive Care in Cancer, 2020, v. 28, n. 12, p. 5943, doi. 10.1007/s00520-020-05443-8
- By:
- Publication type:
- Article
Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A pharmacist check of patients' infection-related condition prior to drug preparation reduces anticancer drug wastage after mixing: a retrospective study.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s40545-023-00518-3
- By:
- Publication type:
- Article
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Efficacy of Afatinib Treatment for a Patient with Leptomeningeal Carcinomatosis.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 3, p. 147, doi. 10.1159/000454727
- By:
- Publication type:
- Article
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e741, doi. 10.1093/oncolo/oyae015
- By:
- Publication type:
- Article
One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. e524, doi. 10.1093/oncolo/oyac060
- By:
- Publication type:
- Article
Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. e1066, doi. 10.1002/onco.13772
- By:
- Publication type:
- Article
Bevacizumab in Combination with TAS‐102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e469, doi. 10.1634/theoncologist.2019-0541
- By:
- Publication type:
- Article
A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin‐Based Chemotherapy‐Induced Nausea and Vomiting in Japan.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e373, doi. 10.1634/theoncologist.2019-0292
- By:
- Publication type:
- Article
Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic.
- Published in:
- Journal of Evaluation in Clinical Practice, 2012, v. 18, n. 4, p. 753, doi. 10.1111/j.1365-2753.2011.01665.x
- By:
- Publication type:
- Article
Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy.
- Published in:
- Medical Oncology, 2011, v. 28, n. 2, p. 488, doi. 10.1007/s12032-010-9487-2
- By:
- Publication type:
- Article
Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.
- Published in:
- Biomedical Chromatography, 2016, v. 30, n. 7, p. 1150, doi. 10.1002/bmc.3642
- By:
- Publication type:
- Article
Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 5, p. 1913, doi. 10.1007/s12325-023-02474-5
- By:
- Publication type:
- Article
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5HT<sub>3</sub>RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy‐induced nausea and vomiting in colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 2, p. 744, doi. 10.1111/cas.14757
- By:
- Publication type:
- Article
Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 27, doi. 10.1007/s10147-024-02663-4
- By:
- Publication type:
- Article
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 17, doi. 10.1007/s10147-024-02652-7
- By:
- Publication type:
- Article
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
- By:
- Publication type:
- Article
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
- By:
- Publication type:
- Article
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
- By:
- Publication type:
- Article
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1257, doi. 10.1007/s10147-021-01910-2
- By:
- Publication type:
- Article